Search Results

There are 6136 results for: content related to: Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Article first published online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 258–272, C. Bunchorntavakul and K. R. Reddy

    Article first published online : 27 MAY 2015, DOI: 10.1111/apt.13264

  3. Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection

    Liver Transplantation

    Volume 22, Issue 4, April 2016, Pages: 446–458, Robert J. Fontana, Robert S. Brown Jr, Ana Moreno-Zamora, Martin Prieto, Shobha Joshi, Maria-Carlota Londoño, Kerstin Herzer, Kristina R. Chacko, Rudolf E. Stauber, Viola Knop, Syed-Mohammed Jafri, Lluís Castells, Peter Ferenci, Carlo Torti, Christine M. Durand, Laura Loiacono, Raffaella Lionetti, Ranjeeta Bahirwani, Ola Weiland, Abdullah Mubarak, Ahmed M. ElSharkawy, Bernhard Stadler, Marzia Montalbano, Christoph Berg, Adriano M. Pellicelli, Stephan Stenmark, Francis Vekeman, Raluca Ionescu-Ittu, Bruno Emond and K. Rajender Reddy

    Article first published online : 28 MAR 2016, DOI: 10.1002/lt.24416

  4. You have free access to this content
    Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C

    American Journal of Transplantation

    Volume 13, Issue 6, June 2013, Pages: 1601–1605, R. J. Fontana, E. A. Hughes, M. Bifano, H. Appelman, D. Dimitrova, R. Hindes and W. T. Symonds

    Article first published online : 17 APR 2013, DOI: 10.1111/ajt.12209

  5. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  6. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report

    Hepatology Research

    Tomokazu Kawaoka, Michio Imamura, Kei Morio, Yuki Nakamura, Masataka Tsuge, C. Nelson Hayes, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Kouhei Ishiyama, Kentaro Ide, Hirotaka Tashiro, Hideki Ohdan and Kazuaki Chayama

    Article first published online : 2 NOV 2015, DOI: 10.1111/hepr.12602

  7. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27533

  8. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Article first published online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  9. You have free access to this content
    Treatment of hepatitis C in liver transplant patients: Interferon out, direct antiviral combos in

    Liver Transplantation

    Volume 21, Issue 4, April 2015, Pages: 423–434, Jennifer C. Price and Norah A. Terrault

    Article first published online : 30 MAR 2015, DOI: 10.1002/lt.24080

  10. Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b

    Hepatology Research

    Phil McEwan, Thomas Ward, Samantha Webster, Yong Yuan, Anupama Kalsekar, Isao Kamae, Masahiro Kobayashi, Ann Tang and Hiromitsu Kumada

    Article first published online : 6 OCT 2015, DOI: 10.1111/hepr.12570

  11. You have free access to this content
    Poster Session 1: Stem Cell Biology; Therapeutics: New Agents (not approved, phase 2–3)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 544A–574A,

    Article first published online : 7 OCT 2015, DOI: 10.1002/hep.28216

  12. You have free access to this content
    Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

    Alimentary Pharmacology & Therapeutics

    A. Majumdar, M. T. Kitson and S. K. Roberts

    Article first published online : 18 APR 2016, DOI: 10.1111/apt.13633

  13. You have free access to this content
    Speaker Abstracts

    Journal of Viral Hepatitis

    Volume 22, Issue S3, September 2015, Pages: 1–18,

    Article first published online : 9 SEP 2015, DOI: 10.1111/jvh.12440

  14. Interferon-free antiviral treatment of chronic hepatitis C in the transplant setting

    Transplant International

    Volume 28, Issue 9, September 2015, Pages: 1011–1024, Sandra Beinhardt, Markus Peck-Radosavljevic, Harald Hofer and Peter Ferenci

    Article first published online : 23 APR 2015, DOI: 10.1111/tri.12577

  15. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 93A–207A,

    Article first published online : 1 OCT 2015, DOI: 10.1002/hep.28162

  16. You have free access to this content
    Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E360–E367, Mika Miura, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Akihisa Tatsumi, Shinichi Takano, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto and Nobuyuki Enomoto

    Article first published online : 10 APR 2014, DOI: 10.1111/hepr.12316

  17. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Article first published online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  18. Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 158–165, K. Kosaka, M. Imamura, C. N. Hayes, H. Abe, N. Hiraga, S. Yoshimi, E. Murakami, T. Kawaoka, M. Tsuge, H. Aikata, D. Miki, H. Ochi, H. Matsui, A. Kanai, T. Inaba and K. Chayama

    Article first published online : 19 JUN 2014, DOI: 10.1111/jvh.12271

  19. You have free access to this content
    HCV Therapy: The Developmental Pipeline

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 429A–447A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26845

  20. Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 6, March 2016, Pages: 674–696, D. Banerjee and K. R. Reddy

    Article first published online : 20 JAN 2016, DOI: 10.1111/apt.13514